The US-Iran War: An Overview
The conflict between the United States and Iran has become one of the most pressing geopolitical issues.
Read MoreThe conflict between the United States and Iran has become one of the most pressing geopolitical issues.
Read MoreAfter Bam Adebayo passed Kobe Bryant for the second most points scored in a single game by an NBA player, controversial discourse has been brewing among fans in regards to ethics, and whether they have a place when it comes to records.
Read MoreAfter writing off Italy before the game even began, a rude awakening was inevitable for Mark DeRosa and the rest of Team USA.
Read MoreBanks in China have extended a large amount of credit in January. On the face of it, it is a very impressive performance. However, if one were to dig a little deeper, there is a lot more to it than what meets the eye.
Read MoreApple has unveiled the MacBook Neo, a new entry level laptop priced at $599, marking one of the company’s most aggressive moves into the budget segment in years.
Read MoreBonds are talked about everywhere; in your classrooms, on the news, and by investors, but most people only have a surface level idea of what they actually are. At the same time, the bond market is actually bigger than the stock market and is the reason for how governments, corporations, municipalities are funded.
Read MoreFrom an investor perspective, the biggest thing separating someone from building wealth is time. The time to start investing is never too early, and almost never too late either. People still hesitate though. A lot of it comes from overthinking the timing. Some wonder if they should wait for a crash, while others worry, they’re already too late.
Read MoreRight now, there are two risks in private credit that I believe are not getting nearly enough attention: coverage ratios deteriorating quietly at the borrower level, and the growing connection between private credit and the traditional banking system. One tells you where stress is building. The other tells you why it matters more than it used to.
Read MoreThe biggest question surrounding the IPO of Generate Biomedicines is whether artificial intelligence can truly change how drugs are created—or if investors are getting ahead of reality. This isn’t just another biotech listing. It’s a test of whether AI can deliver real outcomes in one of the most complex and capital-intensive industries in the world.
Read MoreNuveen is making one of the biggest moves in the asset management industry this year, agreeing to acquire Schroders for about $13.5 billion. The deal will combine two major global investment firms and create a powerhouse with nearly $2.5 trillion in assets under management.
Read More